It is clear that the cause of fatigue is complex, infuenced by both events occurring in the periphery and the central nervous system (CNS). It has been suggested that exercise-induced changes in serotonin (5-HT), dopamine (DA), and noradrenaline (NA) concentrations contribute to the onset of fatigue during prolonged exercise. Serotonin has been linked to fatigue because of its documented role in sleep, feelings of lethargy and drowsiness, and loss of motivation, whereas increased DA and NA neurotransmission favors feelings of motivation, arousal, and reward. 5-HT has been shown to increase during acute exercise in running rats and to remain high at the point of fatigue. DA release is also elevated during exercise but appears to fall at exhaustion, a response that may be important in the fatigue process. The rates of 5-HT and DA/NA synthesis largely depend on the peripheral availability of the amino acids tryptophan (TRP) and tyrosine (TYR), with increased brain delivery increasing serotonergic and DA/NA activity, respectively. TRP, TYR, and the branched-chained amino acids (BCAAs) use the same transporter to pass through the blood-brain barrier, meaning that the plasma concentration ratio of these amino acids is thought to be a very important marker of neurotransmitter synthesis. Pharmacological manipulation of these neurotransmitter systems has provided support for an important role of the CNS in the development of fatigue. Work conducted over the last 20 y has focused on the possibility that manipulation of neurotransmitter precursors may delay the onset of fatigue. Although there is evidence that BCAA (to limit 5-HT synthesis) and TYR (to elevate brain DA/NA) ingestion can influence perceived exertion and some measures of mental performance, the results of several apparently well-controlled laboratory studies have yet to demonstrate a clear positive effect on exercise capacity or performance. There is good evidence that brain neurotransmitters can play a role in the development of fatigue during prolonged exercise, but nutritional manipulation of these systems through the provision of amino acids has proven largely unsuccessful.
Search Results
You are looking at 1 - 3 of 3 items for
- Author: Phil Watson x
- Refine by Access: All Content x
Amino Acids and the Brain: Do They Play a Role in “Central Fatigue”?
Romain Meeusen and Phil Watson
Perceptions of Effective Training Practices in League of Legends: A Qualitative Exploration
Callum Abbott, Matthew Watson, and Phil Birch
While scientific interest in electronic sports (esports) is steadily growing, there remains an absence of research evidence concerning training practices in specific esports such as League of Legends. Anecdotal evidence suggests that current approaches to training may be suboptimal in terms of performance and, concerningly, linked to negative consequences for player health and well-being. In order to address the lack of literature and aid understanding of the (in)effectiveness of current training practices in esports, our study sought to qualitatively examine the experiences and perceptions of training in a sample of professional and semiprofessional League of Legends players. Through interviews with 10 players who ranked in the top 0.24% of the playing population, three core themes were identified: (a) the state of training, (b) training experiences, and (c) motivational change. This study provides important insights into current training practices in esports and players’ perceptions of the (in)effectiveness of these practices. The paper concludes with practical recommendations for coaches and support staff working in esports.
Improvement of Sprint Performance in Wheelchair Sportsmen With Caffeine Supplementation
Terri S. Graham-Paulson, Claudio Perret, Phil Watson, and Victoria L. Goosey-Tolfrey
Purpose:
Caffeine can be beneficial during endurance and repeated-sprint exercise in able-bodied individuals performing leg or wholebody exercise. However, little evidence exists regarding its effects during upper-body exercise. This study therefore aimed to investigate the effects of caffeine on sprint (SPR) and 4-min maximal-push (PUSH) performance in wheelchair sportsmen.
Methods:
Using a double-blind, placebo-controlled, crossover design, 12 male wheelchair rugby players (age 30.0 ± 7.7 y, body mass 69.6 ± 15.3 kg, training 11.1 ± 3.5 h/wk) completed 2 exercise trials, separated by 7–14 d, 70 min after ingestion of 4 mg/kg caffeine (CAF) or dextrose placebo (PLA). Each trial consisted of four 4-min PUSHes and 3 sets of 3 × 20-m SPRs, each separated by 4 min rest. Participants responded to the Felt Arousal (a measure of perceived arousal), Feeling (a measure of the affective dimension of pleasure/displeasure), and rating-of-perceived-exertion (RPE) scales. Salivary caffeine secretion rates were measured.
Results:
Average SPR times were faster during CAF than PLA during SPR 1 and SPR 2 (P = .037 and .016). There was no influence of supplementation on PUSHes 2–4 (P > .099); however, participants pushed significantly farther during PUSH 1 after CAF than after PLA (mean ± SD 677 ± 107 and 653 ± 118 m, P = .047). There was no influence of CAF on arousal or RPE scores (P > .132). Feeling scores improved over the course of the CAF trial only (P = .017) but did not significantly differ between trials (P > .167). Pre-warm-up (45 min postingestion) salivary CAF secretion rates were 1.05 ± 0.94 and 0.08 ± 0.05 μg/min for CAF and PLA, respectively.
Conclusion:
Acute CAF supplementation can improve both 20-m-sprint performance and a 1-off bout of short-term endurance performance in wheelchair sportsmen.